781 related articles for article (PubMed ID: 26907882)
1. Management of NAFLD: a stage-based approach.
Rinella ME; Sanyal AJ
Nat Rev Gastroenterol Hepatol; 2016 Apr; 13(4):196-205. PubMed ID: 26907882
[TBL] [Abstract][Full Text] [Related]
2. Nonalcoholic Fatty Liver Disease: Pathophysiology and Management.
Carr RM; Oranu A; Khungar V
Gastroenterol Clin North Am; 2016 Dec; 45(4):639-652. PubMed ID: 27837778
[TBL] [Abstract][Full Text] [Related]
3. NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN).
Vos MB; Abrams SH; Barlow SE; Caprio S; Daniels SR; Kohli R; Mouzaki M; Sathya P; Schwimmer JB; Sundaram SS; Xanthakos SA
J Pediatr Gastroenterol Nutr; 2017 Feb; 64(2):319-334. PubMed ID: 28107283
[TBL] [Abstract][Full Text] [Related]
4. Nonalcoholic Fatty Liver Disease Review: Diagnosis, Treatment, and Outcomes.
Ahmed A; Wong RJ; Harrison SA
Clin Gastroenterol Hepatol; 2015 Nov; 13(12):2062-70. PubMed ID: 26226097
[TBL] [Abstract][Full Text] [Related]
5. Macrophage activation marker soluble CD163 and non-alcoholic fatty liver disease in morbidly obese patients undergoing bariatric surgery.
Kazankov K; Tordjman J; Møller HJ; Vilstrup H; Poitou C; Bedossa P; Bouillot JL; Clement K; Grønbaek H
J Gastroenterol Hepatol; 2015 Aug; 30(8):1293-300. PubMed ID: 25772748
[TBL] [Abstract][Full Text] [Related]
6. Nonalcoholic steatohepatitis: emerging targeted therapies to optimize treatment options.
Milic S; Mikolasevic I; Krznaric-Zrnic I; Stanic M; Poropat G; Stimac D; Vlahovic-Palcevski V; Orlic L
Drug Des Devel Ther; 2015; 9():4835-45. PubMed ID: 26316717
[TBL] [Abstract][Full Text] [Related]
7. Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH.
Traussnigg S; Kienbacher C; Halilbasic E; Rechling C; Kazemi-Shirazi L; Hofer H; Munda P; Trauner M
Dig Dis; 2015; 33(4):598-607. PubMed ID: 26159280
[TBL] [Abstract][Full Text] [Related]
8. Management and diagnosis of fatty liver disease.
Schneier AT; Citti CC; Dieterich DT
Expert Rev Gastroenterol Hepatol; 2015 May; 9(5):671-83. PubMed ID: 25716275
[TBL] [Abstract][Full Text] [Related]
9. Effect of Weight Loss, Diet, Exercise, and Bariatric Surgery on Nonalcoholic Fatty Liver Disease.
Hannah WN; Harrison SA
Clin Liver Dis; 2016 May; 20(2):339-50. PubMed ID: 27063273
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis and novel treatment options for non-alcoholic steatohepatitis.
Wong VW; Chitturi S; Wong GL; Yu J; Chan HL; Farrell GC
Lancet Gastroenterol Hepatol; 2016 Sep; 1(1):56-67. PubMed ID: 28404113
[TBL] [Abstract][Full Text] [Related]
11. Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management.
McPherson S; Hardy T; Henderson E; Burt AD; Day CP; Anstee QM
J Hepatol; 2015 May; 62(5):1148-55. PubMed ID: 25477264
[TBL] [Abstract][Full Text] [Related]
12. Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology.
Calvo N; Beltrán-Debón R; Rodríguez-Gallego E; Hernández-Aguilera A; Guirro M; Mariné-Casadó R; Millá L; Alegret JM; Sabench F; del Castillo D; Vinaixa M; Rodríguez MÀ; Correig X; García-Álvarez R; Menendez JA; Camps J; Joven J
World J Gastroenterol; 2015 Jun; 21(24):7529-44. PubMed ID: 26140000
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease.
Satapathy SK; Sanyal AJ
Semin Liver Dis; 2015 Aug; 35(3):221-35. PubMed ID: 26378640
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update.
Athyros VG; Tziomalos K; Katsiki N; Doumas M; Karagiannis A; Mikhailidis DP
World J Gastroenterol; 2015 Jun; 21(22):6820-34. PubMed ID: 26078558
[TBL] [Abstract][Full Text] [Related]
15. Liver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significance.
Stål P
World J Gastroenterol; 2015 Oct; 21(39):11077-87. PubMed ID: 26494963
[TBL] [Abstract][Full Text] [Related]
16. Non-alcoholic fatty liver disease: when to intervene and with what.
Than NN; Newsome PN
Clin Med (Lond); 2015 Apr; 15(2):186-90. PubMed ID: 25824073
[TBL] [Abstract][Full Text] [Related]
17. [Non alcoholic steatohepatitis (NASH)].
Coronel M E; Coronel C M
Rev Gastroenterol Peru; 2016; 36(1):58-65. PubMed ID: 27131942
[TBL] [Abstract][Full Text] [Related]
18. Nonalcoholic Fatty Liver Disease Management: Dietary and Lifestyle Modifications.
Nguyen V; George J
Semin Liver Dis; 2015 Aug; 35(3):318-37. PubMed ID: 26378647
[TBL] [Abstract][Full Text] [Related]
19. Nonalcoholic fatty liver disease: a challenge for pediatricians.
Nobili V; Alkhouri N; Alisi A; Della Corte C; Fitzpatrick E; Raponi M; Dhawan A
JAMA Pediatr; 2015 Feb; 169(2):170-6. PubMed ID: 25506780
[TBL] [Abstract][Full Text] [Related]
20. Association of nonalcoholic fatty liver disease with cardiovascular risk factors in obese adolescents: the role of interdisciplinary therapy.
Sanches PL; de Piano A; Campos RM; Carnier J; de Mello MT; Elias N; Fonseca FA; Masquio DC; da Silva PL; Corgosinho FC; Tock L; Oyama LM; Tufik S; Dâmaso AR
J Clin Lipidol; 2014; 8(3):265-72. PubMed ID: 24793347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
